載入...
The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs
A vaccine that prevents hepatitis C virus (HCV) infection is urgently needed to support an emerging global elimination program. However, vaccine development has been confounded because of HCV's high degree of antigenic variability and the preferential induction of type‐specific immune responses...
Na minha lista:
| 發表在: | Hepatology |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5408392/ https://ncbi.nlm.nih.gov/pubmed/27997681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28989 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|